MPH Health Care AG
XETRA:93M1
Intrinsic Value
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. [ Read More ]
The intrinsic value of one
93M1
stock under the Base Case scenario is
22.97
EUR.
Compared to the current market price of 20.6 EUR,
MPH Health Care AG
is
Undervalued by 10%.
MPH Health Care AG's market capitalization is 88.2m EUR.
93M1 stock price is 20.6 EUR.
93M1 stock price (20.6 EUR) is 10% less than its Intrinsic Value (22.97 EUR).
93M1 stock (0.2 EUR) is 99% less than its price (20.6 EUR). Open Relative Valuation
93M1 has upside potential of 117% compared to the average analyst price target.
Open Wall St Estimates
93M1's ROIC (Return on Invested Capital) has decreased in the last 3 years from 0% to -1%, and is approaching profitability.
93M1's Revenue has dropped by 1% over the past 12 months.
93M1's short-term assets (4m EUR) exceed its short-term liabilties (3m EUR).
93M1's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -1%.
93M1's ROE (Return on Equity) for the past 12 months is very high and is equal to 27%.
93M1's ROE (Return on Equity) has significantly increased in the last 3 years from -53% to 27%.
93M1 has positive Net Debt. This means that the company has more debt (10m EUR) than cash and short-term investments (3m EUR).
93M1 has negative three-year average ROIC (Return on Invested Capital): 0%. The company is not efficient at using invested capital to generate operating income.
93M1 has negative Operating Income for the last twelve months.
93M1 has positive Net Income for the last twelve months.
93M1 has negative three-year average ROE (Return on Equity): -10%. The company is not efficient at transforming stockholders' equity into net income.
93M1 has positive Free Cash Flow for the last twelve months.
93M1's Altman Z-Score is very high and is equal to 4.02.
93M1's D/E (Debt to Equity) is very low and is equal to 0.05.
93M1's long-term assets (221m EUR) exceed its long-term liabilties (15m EUR).
93M1 doesn't generate enough operating income (-1m EUR) to safely cover interest payments on its debt (185k EUR).
Valuation Backtest
MPH Health Care AG
Run backtest to discover the historical profit from buying and selling
93M1
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
MPH Health Care AG
Balance Sheet Decomposition
MPH Health Care AG
| Current Assets | 3.5m |
| Cash & Short-Term Investments | 3.4m |
| Other Current Assets | 165.5k |
| Non-Current Assets | 217.3m |
| Long-Term Investments | 217.3m |
| PP&E | 14.7k |
| Current Liabilities | 3.3m |
| Accounts Payable | 32.9k |
| Accrued Liabilities | 119.5k |
| Other Current Liabilities | 3.1m |
| Non-Current Liabilities | 11.5m |
| Long-Term Debt | 9.9m |
| Other Non-Current Liabilities | 1.6m |
Earnings Waterfall
MPH Health Care AG
|
Revenue
|
34.2k
EUR
|
|
Operating Expenses
|
-1.1m
EUR
|
|
Operating Income
|
-1m
EUR
|
|
Other Expenses
|
50.7m
EUR
|
|
Net Income
|
49.7m
EUR
|
Free Cash Flow Analysis
MPH Health Care AG
93M1 Profitability Score
Profitability Due Diligence
MPH Health Care AG's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
MPH Health Care AG's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
93M1 Solvency Score
Solvency Due Diligence
MPH Health Care AG's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
MPH Health Care AG's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
93M1 Price Targets Summary
MPH Health Care AG
According to Wall Street analysts, the average 1-year price target for
93M1
is 44.79 EUR
with a low forecast of 44.35 EUR and a high forecast of 46.11 EUR.
Shareholder Return
93M1 Price
MPH Health Care AG
| Average Annual Return | -19.24% |
| Standard Deviation of Annual Returns | 18.84% |
| Max Drawdown | -78% |
| Market Capitalization | 88.2m EUR |
| Shares Outstanding | 4 281 384 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
MPH Health Care AG
Country
Industry
Market Cap
Dividend Yield
Description
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
Contact
IPO
Employees
Officers
The intrinsic value of one
93M1
stock under the Base Case scenario is
22.97
EUR.
Compared to the current market price of 20.6 EUR,
MPH Health Care AG
is
Undervalued by 10%.
You don't have any saved screeners yet
